Literature DB >> 9674820

Serotonin syndrome induced by transitioning from phenelzine to venlafaxine: four patient reports.

S Diamond1, B J Pepper, M L Diamond, F G Freitag, G J Urban, A K Erdemoglu.   

Abstract

With the use of the newer antidepressants beyond the traditional tricyclics and monoamine oxidase inhibitors, newer options in headache prophylaxis are provided as well as the potential for undesirable and even potentially life-threatening interactions between medications. In this article, four patient reports of a specific interaction--the serotonin syndrome--are presented. These events resulted from transitioning headache patients from an older antidepressant (phenelzine) to a newer antidepressant (venlafaxine).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9674820     DOI: 10.1212/wnl.51.1.274

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  3 in total

1.  Serotonin Syndrome following Introduction of Venlafaxine following Withdrawal of Phenelzine: Implications for Drug Washout Periods.

Authors:  Sarah J Yates; Niraj Ahuja; Sarah E Gartside; R Hamish McAllister-Williams
Journal:  Ther Adv Psychopharmacol       Date:  2011-08

Review 2.  Venlafaxine extended-release: a review of its use in the management of major depression.

Authors:  K Wellington; C M Perry
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 3.  Antidepressants in long-term migraine prevention.

Authors:  Horst J Koch; Tim P Jürgens
Journal:  Drugs       Date:  2009       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.